Amgen Inc. (LON: 0R0T)
London
· Delayed Price · Currency is GBP · Price in USD
286.25
+3.00 (1.06%)
At close: Jan 31, 2025
Amgen Revenue
Amgen had revenue of $8.50B USD in the quarter ending September 30, 2024, with 23.18% growth. This brings the company's revenue in the last twelve months to $32.53B, up 21.25% year-over-year. In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth.
Revenue (ttm)
$32.53B
Revenue Growth
+21.25%
P/S Ratio
n/a
Revenue / Employee
$1.22M
Employees
26,700
Market Cap
123.43B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |